We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Restaurant Brands International
QSR
$25.1B
| $843K | 0.01% |
+21,947
| New | +$875K |
|
|
MBLY
602
DELISTED
Mobileye N.V.
MBLY
| $839K | 0.01% |
+19,969
| New | +$777K |
|
603
Interface
TILE
$1.91B
| $835K | 0.01% |
+40,200
| New | +$723K |
|
|
RGC
604
DELISTED
Regal Entertainment Group
RGC
| $819K | 0.01% |
+35,852
| New | +$794K |
|
605
ENI
E
$76B
| $812K | 0.01% |
+23,464
| New | +$815K |
|
606
Navient
NAVI
$774M
| $806K | 0.01% |
39,630
-221,131
| -85% | -$4.54M |
|
607
Equity Residential
EQR
$25.4B
| $801K | 0.01% |
+10,293
| New | +$804K |
|
|
GAME
608
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
| $793K | 0.01% |
123,870
+68,862
| +125% | +$395K |
|
609
Humana
HUM
$46.7B
| $791K | 0.01% |
+4,445
| New | +$703K |
|
610
1-800-Flowers.com
FLWS
$245M
| $789K | 0.01% |
+66,726
| New | +$680K |
|
|
SWFT
611
DELISTED
Swift Transportation Company
SWFT
| $776K | 0.01% |
29,821
+5,068
| +20% | +$139K |
|
|
UFS
612
DELISTED
DOMTAR CORPORATION (New)
UFS
| $773K | 0.01% |
+16,734
| New | +$705K |
|
613
BJ's Restaurants
BJRI
$1.41B
| $771K | 0.01% |
+15,294
| New | +$753K |
|
614
Icon
ICLR
$12.8B
| $769K | 0.01% |
10,910
-199,839
| -95% | -$12.4M |
|
615
Pilgrim's Pride
PPC
$6.82B
| $768K | 0.01% |
+33,997
| New | +$966K |
|
|
AGRX
616
DELISTED
Agile Therapeutics
AGRX
| $749K | 0.01% |
+40
| New | +$701K |
|
|
HCBK
617
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $748K | 0.01% |
71,343
+5,453
| +8% | +$53.2K |
|
|
BEAV
618
DELISTED
B/E Aerospace Inc
BEAV
| $746K | 0.01% |
11,723
-2,684
| -19% | -$165K |
|
619
Frontline
FRO
$8.75B
| $743K | 0.01% |
+66,323
| New | +$925K |
|
620
Acadia Pharmaceuticals
ACAD
$4.25B
| $739K | 0.01% |
+22,686
| New | +$780K |
|
621
Viavi Solutions
VIAV
$9.75B
| $729K | 0.01% |
+97,710
| New | +$742K |
|
622
Red Robin
RRGB
$134M
| $727K | 0.01% |
+8,359
| New | +$678K |
|
623
Archer Daniels Midland
ADM
$41.4B
| $719K | 0.01% |
15,159
-3,511
| -19% | -$167K |
|
|
VNET
624
VNET Group
VNET
$2.05B
| $718K | 0.01% |
40,650
+49
| +0.1% | +$849 |
|
|
PNRA
625
DELISTED
Panera Bread Co
PNRA
| $705K | 0.01% |
4,409
-5,599
| -56% | -$928K |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.